Chemotherapy combined with immune checkpoint inhibitors may overcome the detrimental effect of high neutrophil-to-lymphocyte ratio prior to treatment in esophageal cancer patients
Hirasawa, Yuya, Kubota, Yutaro, Mura, Emiko, Suzuki, Risako, Tsurui, Toshiaki, Iriguchi, Nana, Ishiguro, Tomoyuki, Ohkuma, Ryotaro, Shimokawa, Masahiro, Ariizumi, Hirotsugu, Horiike, Atsushi, Wada, Satoshi, Yamashita, Takeshi, Ariyoshi, Tomotake, Goto, Satoru, Otsuka, Koji, Murakami, Masahiko, Kiuchi, Yuji, Yoshimura, Kiyoshi, Tsunoda, Takuya
Published in Frontiers in oncology (11.10.2024)
Published in Frontiers in oncology (11.10.2024)
Get full text
Journal Article
Case Report: Combined pembrolizumab, 5-fluorouracil, and cisplatin therapy were remarkably effective in p16-positive squamous cell carcinoma of unknown primary
Suzuki, Risako, Hamada, Kazuyuki, Ohkuma, Ryotaro, Homma, Mayumi, Tsurui, Toshiaki, Iriguchi, Nana, Ishiguro, Tomoyuki, Hirasawa, Yuya, Ariizumi, Hirotsugu, Kubota, Yutaro, Horiike, Atsushi, Yoshimura, Kiyoshi, Wada, Satoshi, Yamochi, Toshiko, Tsunoda, Takuya
Published in Frontiers in oncology (10.07.2023)
Published in Frontiers in oncology (10.07.2023)
Get full text
Journal Article
Maximum Efficacy of Immune Checkpoint Inhibitors Occurs in Esophageal Cancer Patients With a Low Neutrophil-to-Lymphocyte Ratio and Good Performance Status Prior to Treatment
Hirasawa, Yuya, Kubota, Yutaro, Mura, Emiko, Suzuki, Risako, Tsurui, Toshiaki, Iriguchi, Nana, Ishiguro, Tomoyuki, Ohkuma, Ryotaro, Shimokawa, Masahiro, Ariizumi, Hirotsugu, Horiike, Atsushi, Wada, Satoshi, Ariyoshi, Tomotake, Goto, Satoru, Otsuka, Koji, Murakami, Masahiko, Kiuchi, Yuji, Yoshimura, Kiyoshi, Hoffman, Robert M, Tsunoda, Takuya
Published in Anticancer research (01.08.2024)
Published in Anticancer research (01.08.2024)
Get full text
Journal Article
Non-classical Monocytes Enhance the Efficacy of Immune Checkpoint Inhibitors on Colon Cancer in a Syngeneic Mouse Model
Goshima, Tsubasa, Ieguchi, Katsuaki, Onishi, Nobuyuki, Shimizu, Takashi, Takayanagi, Daisuke, Watanabe, Makoto, Fujimoto, Yuki, Ohkuma, Ryotaro, Suzuki, Risako, Tsurui, Toshiaki, Mura, Emiko, Iriguchi, Nana, Ishiguro, Tomoyuki, Shimokawa, Masahiro, Hirasawa, Yuya, Kubota, Yutaro, Ariizumi, Hirotsugu, Horiike, Atsushi, Yoshimura, Kiyoshi, Tsuji, Mayumi, Kiuchi, Yuji, Kobayashi, Shinichi, Fujishiro, Jun, Hoffman, Robert M, Tsunoda, Takuya, Wada, Satoshi
Published in Anticancer research (01.01.2024)
Published in Anticancer research (01.01.2024)
Get full text
Journal Article
P48-8 A case of primary lung cancer that led to the diagnosis of SMARCA4-deficient thoracic sarcoid tumor by oncogene panel testing
Iriguchi, Nana, Horiike, Atsushi, Ishiguro, Tomoyuki, Ohkuma, Ryotaro, Nishihara, Shigetoshi, Matsukuma, Satoshi, Ariizumi, Hirotsugu, Yoshida, Reiko, Kubota, Yutaro, Hanaoka, Ryosuke, Wada, Satoshi, Tsurutani, Junji, Yoshimura, Kiyoshi, Yamochi, Toshiko, Takeuchi, Kengo, Takahashi, Shunji, Nakamura, Seigo, Tsunoda, Takuya
Published in Annals of oncology (01.07.2021)
Published in Annals of oncology (01.07.2021)
Get full text
Journal Article
Monocyte subsets associated with the efficacy of anti‑PD‑1 antibody monotherapy
Ohkuma, Ryotaro, Fujimoto, Yuki, Ieguchi, Katsuaki, Onishi, Nobuyuki, Watanabe, Makoto, Takayanagi, Daisuke, Goshima, Tsubasa, Horiike, Atsushi, Hamada, Kazuyuki, Ariizumi, Hirotsugu, Hirasawa, Yuya, Ishiguro, Tomoyuki, Suzuki, Risako, Iriguchi, Nana, Tsurui, Toshiaki, Sasaki, Yosuke, Homma, Mayumi, Yamochi, Toshiko, Yoshimura, Kiyoshi, Tsuji, Mayumi, Kiuchi, Yuji, Kobayashi, Shinichi, Tsunoda, Takuya, Wada, Satoshi
Published in Oncology letters (01.09.2023)
Published in Oncology letters (01.09.2023)
Get full text
Journal Article
Novel quantitative immunohistochemical analysis for evaluating PD-L1 expression with phosphor-integrated dots for predicting the efficacy of patients with cancer treated with immune checkpoint inhibitors
Ohkuma, Ryotaro, Miura, Sakiko, Muto, Satoshi, Toyomasu, Yoshitaka, Fujimoto, Yuki, Ieguchi, Katsuaki, Onishi, Nobuyuki, Shimizu, Takashi, Watanabe, Makoto, Takayanagi, Daisuke, Goshima, Tsubasa, Horiike, Atsushi, Hamada, Kazuyuki, Ariizumi, Hirotsugu, Shimokawa, Masahiro, Hirasawa, Yuya, Ishiguro, Tomoyuki, Suzuki, Risako, Iriguchi, Nana, Tsurui, Toshiaki, Mura, Emiko, Takenoshita, Sachiko, Numajiri, Kazuki, Okabe, Naoyuki, Yoshimura, Kiyoshi, Tsuji, Mayumi, Kiuchi, Yuji, Yajima, Toshiki, Ishida, Hideyuki, Suzuki, Hiroyuki, Yamochi, Toshiko, Kobayashi, Shinichi, Tsunoda, Takuya, Wada, Satoshi
Published in Frontiers in immunology (18.09.2023)
Published in Frontiers in immunology (18.09.2023)
Get full text
Journal Article
46 Genetic analysis of tumor cells derived from the stress of immune response for understanding of immunotherapy
Ishiguro, Tomoyuki, Takayanagi, Daisuke, Tsurui, Toshiaki, Suzuki, Risako, Iriguchi, Nana, Hirasawa, Yuya, Ohkuma, Ryotaro, Ariizumi, Hirotsugu, Kubota, Yutaro, Hamada, Kazuyuki, Horiike, Atsushi, Wada, Satoshi, Yoshimura, Kiyoshi, Takeda, Kazuyoshi, Tsunoda, Takuya
Published in Journal for immunotherapy of cancer (01.11.2022)
Published in Journal for immunotherapy of cancer (01.11.2022)
Get full text
Journal Article
Abstract CT032: Promotive clinical effects of pembrolizumab with necitumumab in patients having advanced non-small cell lung cancer with PD-L1 expression of 50% or higher in a phase II study (K-TAIL-202)
Horiike, Atsushi, Wakui, Hiroshi, Sugawara, Shunichi, Minegishi, Yuji, Tasaka, Sadatomo, Kusumoto, Sojiro, Sakatani, Toshio, Suzuki, Hiroyuki, Hosomi, Yukio, Tambo, Yuichi, Shimokawa, Tsuneo, Ishida, Hiroo, Miyauchi, Eisaku, Naoki, Katsuhiko, Fukuhara, Tatsuro, Mura, Emiko, Tsurui, Toshiaki, Suzuki, Risako, Iriguchi, Nana, Ishiguro, Tomoyuki, Hirasawa, Yuya, Manabe, Ryo, Shimokawa, Masahiro, Ohkuma, Ryotaro, Ariizumi, Hirotsugu, Kubota, Yutaro, Hamada, Kazuyuki, Takenoshita, Sachiko, Ryu, Kakei, Sambe, Takehiko, Inoue, Eisuke, Wada, Satoshi, Yoshimura, Kiyoshi, Sagara, Hironori, Kobayashi, Shinichi, Tsunoda, Takuya
Published in Cancer research (Chicago, Ill.) (05.04.2024)
Published in Cancer research (Chicago, Ill.) (05.04.2024)
Get full text
Journal Article
Abstract 6179: Increased circulating PD-L1 expressing CD14 high CD16 negative classical monocytes correlate with poor prognosis in cancer patients treated with PD-1 blockade therapies
Ohkuma, Ryotaro, Ieguchi, Katsuaki, Watanabe, Makoto, Goshima, Tsubasa, Onoue, Rie, Hamada, Kazuyuki, Kubota, Yutaro, Horiike, Atsushi, Tsurui, Toshiaki, Suzuki, Risako, Iriguchi, Nana, Ishiguro, Tomoyuki, Hirasawa, Yuya, Ariizumi, Hirotsugu, Yoshimura, Kiyoshi, Tsuji, Mayumi, Kiuchi, Yuji, Kobayashi, Shinichi, Tsunoda, Takuya, Wada, Satoshi
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Get full text
Journal Article